ABT vs. ISRG, BSX, SYK, MDT, BDX, EW, IDXX, RMD, DXCM, and STE
Should you be buying Abbott Laboratories stock or one of its competitors? The main competitors of Abbott Laboratories include Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Abbott Laboratories vs.
Abbott Laboratories (NYSE:ABT) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, community ranking, media sentiment and earnings.
In the previous week, Abbott Laboratories had 10 more articles in the media than Intuitive Surgical. MarketBeat recorded 71 mentions for Abbott Laboratories and 61 mentions for Intuitive Surgical. Abbott Laboratories' average media sentiment score of 1.32 beat Intuitive Surgical's score of 1.15 indicating that Abbott Laboratories is being referred to more favorably in the media.
Abbott Laboratories has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500.
Intuitive Surgical has a net margin of 28.51% compared to Abbott Laboratories' net margin of 13.99%. Abbott Laboratories' return on equity of 20.18% beat Intuitive Surgical's return on equity.
Abbott Laboratories presently has a consensus target price of $131.57, indicating a potential upside of 15.97%. Intuitive Surgical has a consensus target price of $554.17, indicating a potential downside of 6.49%. Given Abbott Laboratories' higher possible upside, equities research analysts plainly believe Abbott Laboratories is more favorable than Intuitive Surgical.
75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.8% of Intuitive Surgical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Intuitive Surgical received 109 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 69.72% of users gave Abbott Laboratories an outperform vote while only 69.09% of users gave Intuitive Surgical an outperform vote.
Summary
Intuitive Surgical beats Abbott Laboratories on 11 of the 18 factors compared between the two stocks.
Get Abbott Laboratories News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Abbott Laboratories Competitors List
Related Companies and Tools
This page (NYSE:ABT) was last updated on 1/20/2025 by MarketBeat.com Staff
